cagrisema cagrilintide semaglutide phase 3 results 2024 2025 obesity Novo Nordisk shares plunge after drug trial disappoints Amylin Commands Weight Novo Nosedives on Underwhelming CagriSema

Your doctor needs to confirm you met ONE of these criteria when you first started taking a GLP-1: Path 1: Higher BMI BMI of 35 or higher No other health conditions required Example: You started Wegovy in 2024 with BMI 37, and now your BMI is 33 you still qualify

503B Outsourcing Facilities: The "Gold Standard" of Safety Congress created the 503B designation to bridge the gap between traditional compounders and pharmaceutical manufacturers

The goal is to provide safe, effective, and accessible treatment

Sources: Gorgojo-Martnez JJ, Mezquita-Raya P, Carretero-Gmez J, et al

The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats